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 ABSTRACT - It was studied  the influence of the antimitotic drug  5 - fluorouracil (5-FU), administered to 
pregnant rats,  on dental germ formation of newborn rats. A total of 125 female aged 90-100 days and  15 male 
adult rats (Rattus rattus norvaegicus, albinus, Wistar) were used. The drug was injected intraperitoneally in 
single doses to females at the 9th, 10th, 11th, 12th and 13th  days of pregnancy. The animals were divided in four 
groups according to the doses administered: 10, 20, 30 and 40 mg/kg. Results show that the drug  induced no 
toxicity to mothers, other than loss of body weight with higher doses (30-40 mg/kg), but  caused in the fetuses 
dental germ anomalies and body external malformations.  The proportion of such anomalies were, besides dose 
dependent, influenced by the day of pregnancy when the drug was administered to the mothers: there was a 
greater sensitivity at the 9th day and   a lesser one  at the 10th day. Higher doses (30-40 mg/kg) caused frequently 
embryonic death or fetal uterine reabsorption. Agenesia  of the dental germ was frequently found.  
Key Words: antimitotic drugs; 5-fluorouracil; dental germ; fetal malformation. 
RESUMO - Foi estudada a influência da droga antimitótica 5-fluoruracil (5-FU), administrada a ratas prenhes 
sobre a formação do germe dental de ratos recém nascidos. Foram utilizadas 125 fêmeas com 90-100 dias de 
idade e 15 machos adultos (Rattus rattus norvaegicus, albinus, Wistar). A droga foi injetada por via 
intraperitoneal a  ratas grávidas, em doses únicas, aos 9º, 10º, 11º , 12º  ou 13 º dias de gestação. Os animais foram 
divididos em quatro subgrupos de acordo com a dose administrada: 10, 20, 30 e 40 mg/kg. Os resultados 
mostraram que nessas doses, o 5-FU não teve efeito  tóxico  nas ratas prenhes, alem de perda de peso com doses 
mais elevadas (30-40 mg/kg), enquanto causou anomalias dentais nos embriões, bem como malformações 
externas. A proporção de tais anomalias foi, alem de dose dependente,  influenciada pelo dia de gestação no qual
antimitótico foi administrado às mães: foi observada maior sensibilidade ao 9º dia e menor ao 10º dia. Doses 
mais elevadas (30-40 mg/kg) causaram freqüentemente morte do embrião e reabsorção fetal. Agenesia do germe 
dentário foi freqüentemente observada. 
Palavras-Chave: drogas antimitóticas; 5-fluorouracil; germe dentário; malformações fetais. 
Introduction
 Antimitotic drugs are  useful for the treatment of 
cancer due to its toxic action to  highly proliferating 
tumor cells. The limitation of its use is that they are 
also toxic to cells of normal tissues in the mitotic 
phase, so that the proliferating normal tissue is 
sensitive to these drugs in proportion to its mitotic 
activity, what means severe unwanted side effects. 
Many observations have been made in drug treated 
cancerous pregnant women and in experimental 
animals given antimitotic drugs. Results show not 
predictable unwanted effects on embryos or 
newborn. It was reported in pregnant women 
(STADLER and KNOWLES, 1971; BLATT et al.,
1980; STEPHENS et al., 1980; TOBIAS and 
BLOOM, 1980; GILILLAND and WEINSTEIN, 
1983;) that some chemotherapic drugs such as 
adriamycin, actinomycin D and vincristin, 
administered  before and  within the first 3 months 
of pregnancy caused  no  problems to the newborn. 
However,  the  authors refer to fetal malformations  
due to alkylating  (cyclophosphamide, bussulfan 
and chlorambucil) and antimetabolic agents 
(aminopterin, thioguanine and 5-fluorouracil) given 
to women during the 3 first months of pregnancy. 
STEPHENS et al. (1980) refer to abortion  of an 
abnormal fetus, from a mother given  5-fluorouracil  
during the 11st-12nd  weeks of pregnancy. 
Experimental studies in rodents, rabbits and 
monkeys have shown embryotoxic and teratological 
effects of  antimitotic drugs. Studies have been 
carried out with 5-fluorouracil (DAGG, 1960; 
WILSON, 1971; SHAH and MACKAY, 1978; 
GRAFTON et al., 1987), adriamicyn and 
daunomicyn (THOMPSON et al., 1976), 3,3-
dimethyl-1-phenyltriazene (FRANK et al., 1989). 
For further pharmacological references on 
antimitotic drugs, see CHABNER et al., (1996).  
The influence of anticancer drugs on dental  
development has been widely studied. The rat  has 
a special experimental  interest due to the 
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continuous growth of incisive teeth, lasting for the 
whole life of the animal. At any time, one can 
observe, in each tooth,  the whole cycle of the 
organ development: growth, calcification and 
eruption (FARRIS and GRIFFITH, 1971; 
NISHMURA and TANIMURA, 1976; DAHL and 
KOPPANG, 1985). Dental anomalies in rats and 
mice related to disturbance of dental growth and 
tissular alterations were observed  with   antimitotic 
drugs:  cyclophosphamide (NORDLINDER, 1971; 
KOPPANG, 1973, 1978; MASSINI, 1975; 
VAHLSING, 1975, 1977; MATHEUS and 
HETEM, 1990; MATHEUS et al., 1994) colchicine 
(DIAS COSTA, 1978; NOGUEIRA et al., 1980, 
1981), doxorubicin (DAHL and KOPPANG, 1985),
5-fluorouracil (DE DEUS and HAN, 1976).  
BASTOS-RAMOS et al., (1992) showed that in 
adult rats 5-fluorouracil did not  disturb dental 
growth, unless when very high near to lethal doses 
were used.  The present research intends  to  study 
the influence of the very potent anticancer drug  5-
fluorouracil, given to mothers in early phases of 
pregnancy, in  increasing doses, on the dental germ 
of their offsprings as well its embryotoxic and  
general teratogenic effects. 
Material and Methods 
 A total of  140 adult rats (Rattus rattus 
norvaegicus, albinus, Wistar), in good controlled 
health conditions were used. 125 were virgin 
females, aged 90-100 days and 15 were adult male 
rats. Males and females were put together and the 
fertilized females were used for the experiment. 
They were divided in four groups, according to the 
doses of  5-flourouracil administered. A control 
group injected with  saline was run in parallel.  The 
drug  was administered intraperitoneally, in single 
doses,  at the 9th, 10th, 11th, 12th and 13th  days of 
pregnancy. Four doses of 5-fluorouracil were used, 
as follows: 10 mg/kg; 20 mg/kg: 30 mg/kg and 40 
mg/kg.  At the 21st  day of pregnancy, the rats were 
anesthetized with ethyl ether, the uterus exposed  
by laparoscopy, the embryos were taken out for the 
observation of an earlier fetuses reabsorption. The 
newborn rats were weighed and observed under 
lens  (4 x magnification)  regarding their external 
characteristics, to check possible malformations. 
For  microscopic studies, the heads were cut off, 
fixed in 10% formol solution for 24 h, cut at medial 
sagital plane, hydrated, dehydrated, diaphanized  
and prepared in paraffin to histology. The tissues 
were examined  by light microscopy. In every 
group, control experiments with saline treated rats 
were run. 
 For statistical analysis of the results, Tuckey test, 
variance analysis and  X2 test were used. 
Results
1. Toxicity of 5-fluorouracil to the pregnant 
rats. No important sign of intoxication was 
observed in 5-FU treated mothers, but a poor 
gain or even loss of body weight in the ones 
injected with higher doses (30-40 mg/kg). In 
these animals, a decrease of 30% of successful 
pregnancy, as compared to controls (100%), was 
observed. However, when these doses were given at 
the 13th  day  fertilization,  the pregnancy was less 
affected. It was not affected at all with doses of 10 
or 20 mg/kg injected in any time of pregnancy. 2. 
Toxicity of 5-FU to fetal uterine implantation. The 
number of uterine embryonic implantation was 
significantly reduced  when the drug was injected  
at the 9th  day of pregnancy, and  it was expressive 
with doses of 30 and 40mg/kg. By the time of birth  
100% of the offspring from control not treated 
mothers were alive.  3. Fetal dental germ 
abnormalities. The abnormalities detected at birth 
were of different kind, as follows: absence of dental 
germ; hyperchromatic and roundish nucleus pulp 
cells; inflammatory processes; reduced bone tissue; 
cleft at the edging of the germ. The proportion of 
abnormalities increased with the doses of 5-FU 
given to mothers and were related to the period of 
pregnancy it was given. With higher doses (30 40 
mg/kg) it was poorly observed due to frequent 
uterine reabsorption. No abnormality was found in 
offspring from  control mothers. Results are 
summarized in Table 1.  4. Fetal gross 
abnormalities. Somatic general abnormalities were 
observed in newborn from 5-FU treated mothers, 
most of which showed also dental  germ problems. 
The abnormalities were: labial cleft; cephalic 
extrusion; cephalic hemorrhage; total or partial 
absence of limbs, fingers or tail; diffuse edema. The 
malformations increased with doses of 5-FU and 
was related to the day of pregnancy the drug was 
administered to the mothers. Results are 
summarized in Table 1. 
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Table 1. Influence of  5-fluorouracil (5-FU), administered to pregnant mothers, on offspring rats: gross somatic 
malformations* and dental abnormalities**. 
Time of pregnancy  Dose of 5-FU Somatic malformation Dental abnormalites 
 (days)  (mg/kg)  (% of animals)  (% of animals) 
90 10 21% malformations 15% abnormalities 
20 20%  malformations 19% abnormalities 
30 100% fetal reabsorption ------
40 100% fetal reabsorption ------
100 10 Normal Normal
20 Normal Normal
30 Normal Normal
40 Normal Normal
110 10 Normal Normal
20 Normal Normal
30 100% fetal reabsorption ------
40 100% fetal reabsorption ------
120 10 Normal Normal
20 22% malformations 20% agenesia 
30 47% malformations 21% agenesia 
40 97% reabsorption/1 dead -----
130 10 Normal Normal
20 Normal Normal
30 72% malformations 20% agenesia 
40 37% fetal reabsorption ------
and 63% dead fetuses 
*Gross somatic malformations: labial cleft; encephalic extrusion; encephalic hemorrhage; total or partial absence of limbs, 
finger or tail;  diffuse edema. **Dental abnormalities: absence of dental germ; hyperchromatic and roundish pulp cells; 
inflammatory processes; reduced bone tissue; cleft at the edge of the germ. 
Discussion
 It is well known that many drugs administered  
in pregnancy, mainly during the early stages, in 
human or animals, can  be damaging to the embryo 
or fetus, inducing premature death and absortion or 
uterine reabsorption. Otherwise, they can cause 
death at birth,  or the newborn  survives with 
morphological or functional  abnormalities. 
Regarding to this, antimitotic drugs, widely used in 
the control of cancer,  are particularly important, 
due to their high  toxicity to growing tissues, being 
a real problem if it has to be given to cancerous 
mother. Why to study the embryonic responses to a 
powerful anticancer drug like 5-fluorouracil, if it is 
clearly expected  to be damaging to such 
organisms? It is important because the experimental 
results in animals, using this and other anticancer 
drugs, as well as clinical observations in cancerous 
pregnant women given antimitotics have shown  
that there are dissimilar  responses, according to the 
drug, the doses and  the  period of pregnancy 
(STADLER and KNOWLES, 1971; TOBIAS e 
BLOOM, 1980; GILILLAND and WEINSTEIN, 
1983; BLATT et al., 1992). As far as to dental 
growth is concerned,  previous experiments in our 
laboratories (BASTOS-RAMOS et al., 1992) have 
shown that  5-fluorouracil exerts  a reduced 
influence on  the dental development of adult rats, 
causing some impairment only when very high 
doses, near to lethal were given. These results allow 
to suppose that dental growing tissues in rats are 
somewhat resistant  to the antimitotic action of this 
drug.  These findings induced to study its influence 
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on embryo’s dental germ formation, when given to 
pregnant mothers, as compared to other 
embryotoxic or teratogenic effects in the same 
animal.  The initial dose chosen for the experiments 
- 40 mg/kg, resulted to be very embryotoxic, giving 
rise to many dead embryos or  very high rates of  
uterine embryonic reabsorption. The mothers 
showed no important signs of intoxication, other 
than loss of weight with higher doses or  poor 
weight gain, which could be related to failing in 
pregnancy in most of them. Using lower doses-20 
and 10 mg/kg, no signs of toxicity to mothers were 
observed but they were appropriated to cause 
embryonic malformations. One can establish  some 
parallel between the percentage of body 
malformations and dental anomalies when 10 and 
20 mg/kg of 5-FU were used. However, with doses 
of 30 mg/kg,  dental germ anomalies were half to 
one third less frequent as compared  to the 
proportion of general body malformations, 
considering  the number of  fetuses examined. Very 
important to the results, other than the doses used, 
were the days of pregnancy in which  5-FU was 
injected. It was chosen the period from the 9th  to 
the 13th  days of pregnancy, as long as it is the most 
important period to embryonic formation of 
structures of the rat head. DAGG (1960) refers that 
the 9th  day is very important for the formation of 
ocular structures. Our  results can be considered  
concordant  with this Author’s finding. As a matter 
of fact, when given at the 9th  day, the occurrence of 
malformations was more frequent with doses of 10 
and 20 mg/kg and carried out total absorption of 
embryos with doses of 30 and 40 mg/kg. The high 
rate of fetal reabsorption is consistent with findings 
of  SHAH and MACKAY (1978) using hamsters 
and 5-fluorouracil. In our experiments the 
sensitivity  was less evident when the drug was 
administered at the 10th and 11th  days: no 
malformations were observed with doses of  10 and 
20 mg/kg although there was no birth with doses of 
30 an 40 mg/kg administered at the 11th day if 
pregnancy. On the other hand, a high rate of 
malformations were observed with 5-FU  injected 
at the 12th day of pregnancy, that is 22% with 20 
mg/kg and 47% with 30 mg/kg.  The 12th  day is 
just the crucial day  for the closing of the palate, 
what could  be related to our results. The least 
sensitivity was observed when 5-Fu was given at 
the 10th  day (100% normal), and at the 13th day of 
pregnancy: with doses of 10 and 20 mg/kg, all 
fetuses were normal; with doses of 30 mg/kg, 20 % 
of the fetuses had agenesia of dental germ  and 
72%, body malformations. At this time, doses of 
40mg/kg, usually leading to total uterine embryo 
reabsorption, gave rise to dead but completely 
formed  fetuses.  The results of this work are poorly 
explained by the current knowledge about rat 
embryology, but are expressive to lead further 
experiments, to clear the influence of doses of 10 
and 20 mg/kg, given to mothers at the 9th  day of 
pregnancy, on the development of dental tissues, 
from birth to adult age. 
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